Skip to the page

Data / Drug companies / Safecor Health, LLC

Safecor Health, LLC: 103 products in the FDA NDC directory, labeler code 48433

Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).

Safecor Health, LLC (labeler code 48433) lists 103 products in the FDA National Drug Code Directory, covering 52 finished drugs by generic name. By type: 96 prescription drugs, 7 over the counter drugs. Its main marketing category is generic drugs (ANDA). The newest product started marketing on September 2, 2026.

The request: Watch Safecor Health, LLC (FDA labeler code 48433): each new product listing and each discontinued product. $10 of work on sign-up, no card.

SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.

Labeler code
48433
Products in commercial distribution
103
Packages
103
Finished drugs by generic name
52
Prescription products
96
Over the counter products
7
Controlled substance products
Schedule IV 5
Flagged as original packager
2 of 2 products that carry the flag
Started marketing in the last 12 months
97
Earliest marketing start
September 20, 2008
openFDA record search
api.fda.gov

Products by marketing category

Share of the company's products in commercial distribution.

Marketing categoryProductsShare
Generic drugs (ANDA)9794.2%
Over the counter monograph drugs54.9%
Other unapproved drugs11%

Products by type

TypeProductsShare
Prescription drugs9693.2%
Over the counter drugs76.8%

Drugs it lists

Finished drugs by generic name, with how many companies list each.

Dosage forms

Dosage formProductsShare
Tablet4038.8%
Tablet, film coated3130.1%
Capsule1514.6%
Capsule, extended release43.9%
Tablet, extended release21.9%
Tablet, film coated, extended release21.9%
Liquid21.9%
Tablet, delayed release11%
Solution/ drops11%
Suspension11%
Capsule, delayed release pellets11%
Solution11%

Pharmacologic classes

FDA established pharmacologic classes of its products.

Newest products

By marketing start date.

ProductProduct NDCDosage formMarketing categoryMarketing start
Ezetimibe48433-161TabletGeneric drugs (ANDA)September 2, 2026
Phytonadione48433-160TabletGeneric drugs (ANDA)September 2, 2026
Doxycycline48433-159CapsuleGeneric drugs (ANDA)September 2, 2026
Doxycycline48433-158CapsuleGeneric drugs (ANDA)September 2, 2026
Sucralfate48433-226SuspensionGeneric drugs (ANDA)July 16, 2026
Lansoprazole48433-051Capsule, delayed release pelletsGeneric drugs (ANDA)June 16, 2026
Amlodipine Besylate48433-157TabletGeneric drugs (ANDA)June 1, 2026
Amlodipine Besylate48433-156TabletGeneric drugs (ANDA)June 1, 2026
Amlodipine Besylate48433-155TabletGeneric drugs (ANDA)June 1, 2026
Amiodarone hydrochloride48433-154TabletGeneric drugs (ANDA)June 1, 2026
Haloperidol48433-153TabletGeneric drugs (ANDA)June 1, 2026
Haloperidol48433-152TabletGeneric drugs (ANDA)June 1, 2026
Haloperidol48433-151TabletGeneric drugs (ANDA)June 1, 2026
Famotidine48433-150Tablet, film coatedGeneric drugs (ANDA)June 1, 2026
Verapamil Hydrochloride48433-145Capsule, extended releaseGeneric drugs (ANDA)May 5, 2026
Spironolactone and Hydrochlorothiazide48433-090TabletGeneric drugs (ANDA)May 5, 2026
Spironolactone48433-089Tablet, film coatedGeneric drugs (ANDA)May 5, 2026
Spironolactone48433-088Tablet, film coatedGeneric drugs (ANDA)May 5, 2026
Spironolactone48433-087Tablet, film coatedGeneric drugs (ANDA)May 5, 2026
Cetirizine Hydrochloride48433-017Tablet, film coatedGeneric drugs (ANDA)April 17, 2026
Imatinib Mesylate48433-050Tablet, film coatedGeneric drugs (ANDA)April 10, 2026
Imatinib Mesylate48433-049Tablet, film coatedGeneric drugs (ANDA)April 10, 2026
Trifluoperazine Hydrochloride48433-143Tablet, film coatedGeneric drugs (ANDA)April 7, 2026
Trifluoperazine Hydrochloride48433-142Tablet, film coatedGeneric drugs (ANDA)April 7, 2026
Trifluoperazine Hydrochloride48433-141Tablet, film coatedGeneric drugs (ANDA)April 7, 2026

CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.